Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M1IO
|
||||
Former ID |
DAP000710
|
||||
Drug Name |
Bacitracin
|
||||
Synonyms |
Altracin; Baciguent; Baciquent; Citracin; Fortracin; Bacitracin A; Bacitracin A1; Bacitracin A2a; Neosporin (TN); Solu-Tracin 50; Partyl-, (10.4)-lactam; L-Asparagine, N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-.alpha.-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-.alpha.-as; 11702_FLUKA; 11702_SIGMA
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antibiotics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C66H103N17O16S
|
||||
Canonical SMILES |
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=<br />O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O<br/>)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC<br />3=CN=CN3)CC4=CC=CC=C4
|
||||
InChI |
1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52-,53-,54-/m0/s1
|
||||
InChIKey |
CLKOFPXJLQSYAH-ABRJDSQDSA-N
|
||||
CAS Number |
CAS 1405-87-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:28669
|
||||
SuperDrug ATC ID |
D06AX05; J01XX10; R02AB04
|
||||
SuperDrug CAS ID |
cas=001405874
|
||||
Target and Pathway | |||||
Target(s) | Insulin-degrading Enzyme | Target Info | Inhibitor | [536012] | |
KEGG Pathway | Alzheimer's disease | ||||
WikiPathways | Alzheimers Disease | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.